Effect of recombinant human thrombopoietin on secondary prevention of thrombocytopenia induced by apatinib combined with chemotherapy in the treatment of advanced bone and soft tissue sarcoma

GONG Runze; LIU Yuan; ZHANG Peng; LI Xian'an; WANG Yaling; ZHANG Bing; HU Haiyan

doi:10.3969/j.issn.1009-0460.2022.01.008

Home>Articles>Effect of recombinant human thrombopoietin on secondary prevention of thrombocytopenia induced by apatinib combined with chemotherapy in the treatment of advanced bone and soft tissue sarcoma

DOI: 10.3969/j.issn.1009-0460.2022.01.008

Effect of recombinant human thrombopoietin on secondary prevention of thrombocytopenia induced by apatinib combined with chemotherapy in the treatment of advanced bone and soft tissue sarcoma

GONG Runze

LIU Yuan

ZHANG Peng

LI Xian'an

WANG Yaling

ZHANG Bing

HU Haiyan

Machine-generated Keywords：

Publication Date：2022-01-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 45-48 )

Chinese Clinical Oncology

ISTICPKU

ISSN：1009-0460

Year, Vol.(Issue)：2022,27(1)